669 related articles for article (PubMed ID: 24374932)
1. New advances of microRNAs in glioma stem cells, with special emphasis on aberrant methylation of microRNAs.
Zhao B; Bian EB; Li J; Li J
J Cell Physiol; 2014 Sep; 229(9):1141-7. PubMed ID: 24374932
[TBL] [Abstract][Full Text] [Related]
2. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
[TBL] [Abstract][Full Text] [Related]
3. Neural stem cells preferentially migrate to glioma stem cells and reduce their stemness phenotypes.
Zhang S; Xie R; Zhao T; Yang X; Han L; Ye F; Lei T; Wan F
Int J Oncol; 2014 Nov; 45(5):1989-96. PubMed ID: 25176161
[TBL] [Abstract][Full Text] [Related]
4. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
[TBL] [Abstract][Full Text] [Related]
5. [New glioma therapy using specific microRNAs].
Halle B; Andersen C; Schulz MK; Kristensen BW
Ugeskr Laeger; 2012 Mar; 174(10):630-3. PubMed ID: 22395010
[TBL] [Abstract][Full Text] [Related]
6. Regulatory roles of miRNA in the human neural stem cell transformation to glioma stem cells.
Liu S; Yin F; Zhang J; Wicha MS; Chang AE; Fan W; Chen L; Fan M; Li Q
J Cell Biochem; 2014 Aug; 115(8):1368-80. PubMed ID: 24519663
[TBL] [Abstract][Full Text] [Related]
7. Targeting glioma stem cells by functional inhibition of a prosurvival oncomiR-138 in malignant gliomas.
Chan XH; Nama S; Gopal F; Rizk P; Ramasamy S; Sundaram G; Ow GS; Ivshina AV; Tanavde V; Haybaeck J; Kuznetsov V; Sampath P
Cell Rep; 2012 Sep; 2(3):591-602. PubMed ID: 22921398
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1.
Bier A; Giladi N; Kronfeld N; Lee HK; Cazacu S; Finniss S; Xiang C; Poisson L; deCarvalho AC; Slavin S; Jacoby E; Yalon M; Toren A; Mikkelsen T; Brodie C
Oncotarget; 2013 May; 4(5):665-76. PubMed ID: 23714687
[TBL] [Abstract][Full Text] [Related]
9. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ
Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1.
Tu Y; Gao X; Li G; Fu H; Cui D; Liu H; Jin W; Zhang Y
Cancer Res; 2013 Oct; 73(19):6046-55. PubMed ID: 23950210
[TBL] [Abstract][Full Text] [Related]
11. Temozolomide decreases invasion of glioma stem cells by down-regulating TGF-β2.
Zhang D; Jing Z; Qiu B; Wu A; Wang Y
Oncol Rep; 2011 Oct; 26(4):901-8. PubMed ID: 21725605
[TBL] [Abstract][Full Text] [Related]
12. Methylation mediated silencing of miR-23b expression and its role in glioma stem cells.
Geng J; Luo H; Pu Y; Zhou Z; Wu X; Xu W; Yang Z
Neurosci Lett; 2012 Oct; 528(2):185-9. PubMed ID: 22982144
[TBL] [Abstract][Full Text] [Related]
13. Comparison of glioma stem cells to neural stem cells from the adult human brain identifies dysregulated Wnt- signaling and a fingerprint associated with clinical outcome.
Sandberg CJ; Altschuler G; Jeong J; Strømme KK; Stangeland B; Murrell W; Grasmo-Wendler UH; Myklebost O; Helseth E; Vik-Mo EO; Hide W; Langmoen IA
Exp Cell Res; 2013 Aug; 319(14):2230-43. PubMed ID: 23791939
[TBL] [Abstract][Full Text] [Related]
14. Selective calcium sensitivity in immature glioma cancer stem cells.
Wee S; Niklasson M; Marinescu VD; Segerman A; Schmidt L; Hermansson A; Dirks P; Forsberg-Nilsson K; Westermark B; Uhrbom L; Linnarsson S; Nelander S; Andäng M
PLoS One; 2014; 9(12):e115698. PubMed ID: 25531110
[TBL] [Abstract][Full Text] [Related]
15. Notch signaling contributes to the maintenance of both normal neural stem cells and patient-derived glioma stem cells.
Hu YY; Zheng MH; Cheng G; Li L; Liang L; Gao F; Wei YN; Fu LA; Han H
BMC Cancer; 2011 Feb; 11():82. PubMed ID: 21342503
[TBL] [Abstract][Full Text] [Related]
16. The emerging role of tumor-suppressive microRNA-218 in targeting glioblastoma stemness.
Gao X; Jin W
Cancer Lett; 2014 Oct; 353(1):25-31. PubMed ID: 25042866
[TBL] [Abstract][Full Text] [Related]
17. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
[TBL] [Abstract][Full Text] [Related]
18. Distinctive epigenomes characterize glioma stem cells and their response to differentiation cues.
Zhou D; Alver BM; Li S; Hlady RA; Thompson JJ; Schroeder MA; Lee JH; Qiu J; Schwartz PH; Sarkaria JN; Robertson KD
Genome Biol; 2018 Mar; 19(1):43. PubMed ID: 29587824
[TBL] [Abstract][Full Text] [Related]
19. Connexin 43 reverses malignant phenotypes of glioma stem cells by modulating E-cadherin.
Yu SC; Xiao HL; Jiang XF; Wang QL; Li Y; Yang XJ; Ping YF; Duan JJ; Jiang JY; Ye XZ; Xu SL; Xin YH; Yao XH; Chen JH; Chu WH; Sun W; Wang B; Wang JM; Zhang X; Bian XW
Stem Cells; 2012 Feb; 30(2):108-20. PubMed ID: 22131169
[TBL] [Abstract][Full Text] [Related]
20. [Genetic and epigenetic markers of gliomas].
Semenova EV; Filatov MV
Tsitologiia; 2013; 55(5):290-9. PubMed ID: 24592735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
